Skip to Content

Routine Use of Antibiotics After Sinus Surgery Questioned

TUESDAY, Jan. 19, 2021 -- Routine use of prophylactic postoperative antibiotics does not improve outcomes following endoscopic sinus surgery (ESS) for chronic rhinosinusitis, according to a study published online Dec. 19 in the International Forum of Allergy & Rhinology.

Ashton E. Lehmann, M.D., from Vanderbilt University in Nashville, Tennessee, and colleagues assessed the impact of post-ESS antibiotics on infection, quality of life, and endoscopic scores. Adults with chronic rhinosinusitis refractory to appropriate medical therapy who underwent ESS were randomly assigned to either an antibiotic (37 patients) or placebo (40 patients).

The researchers found that placebo was noninferior to antibiotic prophylaxis with regard to the postoperative 22-item Sino-Nasal Outcome Test questionnaire score. For the Lund-Kennedy endoscopic scores, there were no significant differences noted between the antibiotic and placebo groups for score trajectories over time or in postoperative infection rates. The antibiotic group did have a significantly higher rate of diarrhea (relative risk, 10.8).

"Our findings suggest that otolaryngologists can rethink the practice of routinely prescribing antibiotics after endoscopic sinus surgery," a coauthor said in a statement. "Antibiotics should still be considered when the benefits outweigh the risks, including [when] complex surgical procedures are performed or if the patient is at greater risk for developing an infection."

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Robotically Assisted Surgical Device Authorized for Transvaginal Hysterectomy

TUESDAY, March 2, 2021 -- A novel robotically assisted surgical device for transvaginal hysterectomy has received marketing authorization approval, the U.S. Food and Drug...

ASH Issues Guidance for Preventing, Treating VTE in Cancer

MONDAY, March 1, 2021 -- In a clinical guideline from the American Society of Hematology, published online Feb. 11 in Blood Advances, recommendations are presented for the...

Optimal Therapy for Esophageal Cancer Feasible in Fit Elderly

FRIDAY, Feb. 26, 2021 -- Patients 70 years and older with locally advanced esophageal or esophagogastric junction (EGJ) cancer should be considered for optimal, potentially...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.